Introducing Detrusitol, a trusted medication manufactured by Pfizer, containing the active substance Tolterodine. Detrusitol is meticulously formulated to provide effective relief for individuals suffering from overactive bladder (OAB) symptoms, including urinary urgency, frequency, and urge incontinence. With its proven efficacy and superior tolerability, Detrusitol stands as a reliable treatment option for those seeking to regain control over their bladder function and improve their quality of life.

Key Features:

1. Tolterodine Formulation: Detrusitol features Tolterodine as its active ingredient, a potent antimuscarinic agent that acts selectively on the bladder’s smooth muscle to reduce involuntary contractions and bladder overactivity. By blocking the action of acetylcholine at muscarinic receptors, Tolterodine helps restore normal bladder function and control.
2. Effective Symptom Relief: Detrusitol is indicated for the treatment of overactive bladder (OAB) symptoms, including urinary urgency, frequency, and urge incontinence. By reducing bladder muscle activity and increasing bladder capacity, Detrusitol alleviates OAB symptoms and provides significant improvement in urinary control and quality of life.
3. Convenient Dosage Form: Detrusitol is available in a convenient tablet form, with each pack containing 56 pills of 2 mg strength. The oral administration allows for easy and precise dosing, facilitating compliance and ensuring consistent symptom relief for patients with OAB.
4. Superior Tolerability: Detrusitol is well-tolerated, with a favorable safety profile that minimizes the risk of adverse effects commonly associated with antimuscarinic medications. The selective action of Tolterodine on bladder muscarinic receptors helps reduce the incidence of systemic side effects, such as dry mouth, constipation, and blurred vision, enhancing patient comfort and satisfaction.
5. Individualized Treatment: Detrusitol offers individualized treatment options tailored to the specific needs and preferences of patients with OAB. Healthcare providers can adjust the dosage and frequency of Detrusitol based on the severity of symptoms, patient response, and presence of comorbidities, ensuring optimal therapeutic outcomes.
6. Quality Assurance: Detrusitol is manufactured by Pfizer, a globally recognized pharmaceutical company known for its commitment to quality, innovation, and patient care. Each tablet undergoes stringent quality control measures to ensure purity, potency, and compliance with regulatory standards, providing patients with confidence in the reliability and effectiveness of Detrusitol.

Detrusitol represents a trusted therapeutic option for individuals struggling with overactive bladder (OAB) symptoms, offering effective relief and improved urinary control with its Tolterodine formulation. With its convenient dosage form, superior tolerability, and individualized treatment approach, Detrusitol empowers patients to manage their OAB symptoms and regain control over their bladder function. Consultation with a healthcare professional is essential to determine if Detrusitol is suitable for individual treatment needs and to ensure safe and effective use.